Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
Login / Signup
Send us Feedback
Neogen (NEOG)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
QUOTE AND NEWS
Day
52 Wk
Vol
Avg Vol
P/E
Mkt Cap
See All
BULLS: REASONS TO BUY
Bulls: Reasons To Buy
Feeling Bullish?
Be the first to explain why this would make a good investment
See All (0)
See All
BEARS: REASONS TO SELL
Bears: Reasons To Sell
Feeling Bearish?
Be the first to explain why this would make a poor investment
See All (0)
more ▼
Discussion
Edit
History
Bookmark
Edit
WIKI ANALYSIS
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a
Top Contributor
. For tips on getting started, check out the
sample article
.
NEOG AT A GLANCE
P/E
►
31.5
AVG
EV/EBITDA
►
18.0
AVG
ROA
►
10.5%
HIGH
ROE
►
11.8%
AVG
Debt to Equity
►
0.122
AVG
Current Ratio
►
6.26
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
Please install
Flash Player
to view this chart.
[
edit
]
References
Categories
:
Pharma & Healthcare
|
Diagnostic Substances